[estimation of the cost in the medical treatment of benign prostatic hyperplasia in navarre, spain].we evaluate the cost and trends in the medical treatment of out patients suffering from lower urinary tract symptoms suggestive of clinical benign prostatic hyperplasia in navarre (spain) between 1998/2002. the estimated number of patients increased each year, to 10% of the male population over the age of 50 in 2002, with a cost of euros 2,557,236 equivalent to 2.4% of the total drug expenditure spending of out patients (euros 106.6 million). the use of tamsulosin tripled and the cost doubled to ...200415248396
Displaying items 1 - 1 of 1